JPH0276804A - Hair tonic - Google Patents
Hair tonicInfo
- Publication number
- JPH0276804A JPH0276804A JP1018134A JP1813489A JPH0276804A JP H0276804 A JPH0276804 A JP H0276804A JP 1018134 A JP1018134 A JP 1018134A JP 1813489 A JP1813489 A JP 1813489A JP H0276804 A JPH0276804 A JP H0276804A
- Authority
- JP
- Japan
- Prior art keywords
- phytyl
- compound
- group
- general formula
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000001256 tonic effect Effects 0.000 title claims abstract description 12
- 150000001875 compounds Chemical class 0.000 claims abstract description 38
- 239000004480 active ingredient Substances 0.000 claims abstract description 8
- 125000002252 acyl group Chemical group 0.000 claims abstract description 6
- 125000001931 aliphatic group Chemical group 0.000 claims abstract description 5
- 125000004423 acyloxy group Chemical group 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 125000002015 acyclic group Chemical group 0.000 claims description 3
- -1 phytyl nicotinate Chemical compound 0.000 abstract description 37
- 150000003839 salts Chemical class 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 9
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract description 7
- 235000001968 nicotinic acid Nutrition 0.000 abstract description 4
- 239000011664 nicotinic acid Substances 0.000 abstract description 4
- 125000001189 phytyl group Chemical group [H]C([*])([H])/C([H])=C(C([H])([H])[H])/C([H])([H])C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])[C@@](C([H])([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])C(C([H])([H])[H])([H])C([H])([H])[H] 0.000 abstract description 3
- 201000004384 Alopecia Diseases 0.000 abstract description 2
- 231100000360 alopecia Toxicity 0.000 abstract description 2
- KAVMXKVKVJNLJV-DVRMEFSISA-N 4-oxo-4-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enoxy]butanoic acid Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\COC(=O)CCC(O)=O KAVMXKVKVJNLJV-DVRMEFSISA-N 0.000 abstract 1
- 230000003450 growing effect Effects 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 239000000203 mixture Substances 0.000 description 17
- 239000003795 chemical substances by application Substances 0.000 description 16
- 230000003779 hair growth Effects 0.000 description 15
- 239000002904 solvent Substances 0.000 description 15
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 235000017557 sodium bicarbonate Nutrition 0.000 description 7
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000004440 column chromatography Methods 0.000 description 6
- 239000001707 (E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-ol Substances 0.000 description 5
- BLUHKGOSFDHHGX-UHFFFAOYSA-N Phytol Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)C=CO BLUHKGOSFDHHGX-UHFFFAOYSA-N 0.000 description 5
- HNZBNQYXWOLKBA-UHFFFAOYSA-N Tetrahydrofarnesol Natural products CC(C)CCCC(C)CCCC(C)=CCO HNZBNQYXWOLKBA-UHFFFAOYSA-N 0.000 description 5
- BOTWFXYSPFMFNR-OALUTQOASA-N all-rac-phytol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)=CCO BOTWFXYSPFMFNR-OALUTQOASA-N 0.000 description 5
- 239000003480 eluent Substances 0.000 description 5
- 239000011259 mixed solution Substances 0.000 description 5
- BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 229930182833 estradiol Natural products 0.000 description 2
- 229960005309 estradiol Drugs 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229940125697 hormonal agent Drugs 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- QSKPZDMBULYMDQ-UHFFFAOYSA-N 1-O-pentadecanoyl-sn-glycerol Natural products CCCCCCCCCCCCCCC(=O)OCC(O)CO QSKPZDMBULYMDQ-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- IMRSJFVOSKBAHD-UHFFFAOYSA-N 2-(2,2,2-trichloroethoxycarbonylamino)acetic acid Chemical compound OC(=O)CNC(=O)OCC(Cl)(Cl)Cl IMRSJFVOSKBAHD-UHFFFAOYSA-N 0.000 description 1
- UBFQLISBLKIYNJ-UHFFFAOYSA-N 4-chloro-2-hydroxy-3-oxo-2-phenylbutanoyl chloride Chemical compound ClCC(=O)C(C(Cl)=O)(O)C1=CC=CC=C1 UBFQLISBLKIYNJ-UHFFFAOYSA-N 0.000 description 1
- 125000002373 5 membered heterocyclic group Chemical group 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 240000007124 Brassica oleracea Species 0.000 description 1
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- QSKPZDMBULYMDQ-KRWDZBQOSA-N MG(15:0/0:0/0:0) Chemical compound CCCCCCCCCCCCCCC(=O)OC[C@@H](O)CO QSKPZDMBULYMDQ-KRWDZBQOSA-N 0.000 description 1
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 125000005530 alkylenedioxy group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000003435 aroyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- ALEXXDVDDISNDU-JZYPGELDSA-N cortisol 21-acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)C[C@@H]2O ALEXXDVDDISNDU-JZYPGELDSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- NJNLIGBFCXFGDO-UHFFFAOYSA-N dioxane;pyridine Chemical compound C1CCOOC1.C1=CC=NC=C1 NJNLIGBFCXFGDO-UHFFFAOYSA-N 0.000 description 1
- 239000004664 distearyldimethylammonium chloride (DHTDMAC) Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000005949 ethanesulfonyloxy group Chemical group 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008266 hair spray Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 229960001067 hydrocortisone acetate Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000003253 isopropoxy group Chemical group [H]C([H])([H])C([H])(O*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000005948 methanesulfonyloxy group Chemical group 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 229960003632 minoxidil Drugs 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 229940111688 monobasic potassium phosphate Drugs 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001038 naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- ATBIAJXSKNPHEI-UHFFFAOYSA-N pyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CC=CN=C1 ATBIAJXSKNPHEI-UHFFFAOYSA-N 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- ZVCDLGYNFYZZOK-UHFFFAOYSA-M sodium cyanate Chemical compound [Na]OC#N ZVCDLGYNFYZZOK-UHFFFAOYSA-M 0.000 description 1
- KFLRWGSAMLBHBV-UHFFFAOYSA-M sodium;pyridine-3-carboxylate Chemical compound [Na+].[O-]C(=O)C1=CC=CN=C1 KFLRWGSAMLBHBV-UHFFFAOYSA-M 0.000 description 1
- 239000012453 solvate Substances 0.000 description 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-O triethylammonium ion Chemical compound CC[NH+](CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-O 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は、新規な養毛剤に関する。ざらに詳しくは、一
般式[I]
R’−0−R2[I ]
1°式中、R1はアシルオキシ基で置換されていてもよ
い炭素数20の非環式分岐状高級脂肪族炭化水素基を:
R2はアシル基を示す。」で表わされる化合物を有効成
分とする養毛剤に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a novel hair nourishing agent. More specifically, the general formula [I] R'-0-R2 [I] 1 In the formula, R1 is an acyclic branched higher aliphatic hydrocarbon group having 20 carbon atoms which may be substituted with an acyloxy group. of:
R2 represents an acyl group. This invention relates to a hair tonic containing a compound represented by the following as an active ingredient.
[従来の技術]
従来、養毛剤には、各種の有効成分が用いられており、
たとえば、セリンおよびメチオニンなどのアミノ酸類ニ
アセチルコリン誘導体などの血管拡張剤:サリチル酸み
よび紫根エキスなどの抗炎症剤:エストラジオールなど
のホルモン剤;ビタミンEなどのビタミン類二角質溶解
剤:湿潤剤:香料;ふけ防止剤:清涼剤:生薬エキス類
;および脂肪酸類などを配合した養毛剤が知られている
。[Conventional technology] Conventionally, various active ingredients have been used in hair nourishing agents.
For example, amino acids such as serine and methionine; vasodilators such as niacetylcholine derivatives; anti-inflammatory agents such as salicylic acid Miyo and purple root extract; hormonal agents such as estradiol; vitamins such as vitamin E; dikeratolytic agents; humectants; fragrances. ; anti-dandruff agents; refreshing agents; crude drug extracts; and hair nourishing agents containing fatty acids and the like are known.
また、特開昭60−4113@には、養毛剤の有効成分
として、奇数の炭素鎖長を有するアルコールまたはその
誘導体が記載されている。ざらに、特開昭61−207
321号には、発毛料の有効成分として、炭素数22〜
34の高級脂肪族アルコールが記載されている。Further, JP-A No. 60-4113@ describes alcohols or derivatives thereof having an odd carbon chain length as an active ingredient of a hair tonic. Zarani, Japanese Patent Publication No. 61-207
No. 321 contains 22 to 22 carbon atoms as the active ingredients of the hair growth agent.
Thirty-four higher aliphatic alcohols have been described.
[発明が解決しようとする課題]
しかしながら、これまでの養毛剤は、いずれもその発毛
効果は十分とは言えないのが実情であつた。[Problems to be Solved by the Invention] However, the reality is that none of the hair growth agents that have been used so far has a sufficient hair growth effect.
[課題を解決するための手段1
本発明者らは、上記の実情に鑑み、副作用がみられず脱
毛症に対して優れた発毛効果を発揮する物質について鋭
意研究した結果、一般式[I]で表わされる化合物が優
れた発毛効果を発揮することを見出し、本発明を完成す
るに至った。[Means for Solving the Problems 1] In view of the above-mentioned circumstances, the present inventors conducted intensive research on substances that exhibit excellent hair growth effects against alopecia without any side effects, and found that the general formula [I ] It was discovered that a compound represented by the following formula exhibits an excellent hair growth effect, and the present invention was completed.
本発明の目的は、優れた発毛効果を発揮する化合物を有
効成分とする養毛剤を提供することにある。An object of the present invention is to provide a hair tonic containing as an active ingredient a compound that exhibits an excellent hair growth effect.
以下に、本発明の詳細な説明する。The present invention will be explained in detail below.
一般式[I]の化合物において、R1における炭素数2
0の非環式分岐状高級脂肪族炭化水素基としては、たと
えば、フィチル基(3,7,11,15−テトラメチル
−2−へキサデセン−1−イル基)、イソフィチル基(
3,7,11,15−テトラメチル−1−へキサデセン
−3−イル基)、ゲラニルリナリル基(3,7,11,
15−テトラメチルヘキザデカンー1.6.10.14
−テトラエン−3−イル基)および7−ヒドロキシメチ
ル−3,11,15−トリメチルヘキサデカン−2,6
,10,14−テトラエン−1−イル基などの基が挙げ
られる。In the compound of general formula [I], the number of carbon atoms in R1 is 2
Examples of the acyclic branched higher aliphatic hydrocarbon group of 0 include phytyl group (3,7,11,15-tetramethyl-2-hexadecen-1-yl group), isophyl group (
3,7,11,15-tetramethyl-1-hexadecen-3-yl group), geranyllinalyl group (3,7,11,
15-tetramethylhexadecane-1.6.10.14
-tetraen-3-yl group) and 7-hydroxymethyl-3,11,15-trimethylhexadecane-2,6
, 10,14-tetraen-1-yl group and the like.
また、R1の置換基におけるアシルオキシ基としては、
後記するR2におけるアシル基と同様の基から構成され
るアシル−〇−基が挙げられる。In addition, as the acyloxy group in the substituent of R1,
Examples include acyl-〇-groups composed of the same groups as the acyl group in R2 described later.
また、R2におけるアシル基としては、たとえば、C2
〜2o脂肪族アシル基、たとえば、アセチル、プロピオ
ニル、ブチリル、イソブチリル、イソバレリル、ピバロ
イル、ラウロイル、バルミトイルおよびステアロイルな
どのCアルカノ2〜20
イル基、アクリロイルなどのCアルケノイ3〜20
ル基、プロピオロイルなどのCアルキノイ3〜20
ル基およびシクロプロピルカルボニル
ロヘキシルカルボニルなどのC シクロアル3〜7
キルカルボニル基;ベンゾイルおよびナフトイルなどの
アロイル基;並びにニコチノイル、イソニコチノイル、
1,4−ジヒドロピリジルカルボニル、プロリル、テノ
イルおよびフロイルなどの5員もしくは6員複素環式カ
ルボニル基などの基が挙げられ、これらは、メチル、エ
チル、n−プロピルおよびイソプロピルなどのC1〜4
アルキル基;シクロプロピル、シクロブチルおよびシク
ロヘキシルなどのC シクロアルキル基;メ1へキ
シ、3〜7
エトキシ、n−プロポキシおよびイソプロポキシなどの
C アルコキシ基;メチルチオ、エチル1〜4
チオ、n−プロピルチオおよびイソプロピルチオなとの
C アルキルチオ基ニアセチルオキシ、1〜4
プロピオニルオキシおよびブチリルオキシなとのC
アシルオキシ基;メチレンジオキシおよ2〜4
びエチレンジオキシなどのC アルキレンジ1〜4
オキシ基;ヒドロキシル基;フェニル、3−ニトロフェ
ニルおよびナフチルなどのアリール基;カルボキシル基
;メトキシカルボニルおよびエトキシカルボニルなどの
C アルコキシカルボ1〜4
ニル基;アミノ基;メチルアミノおよびエチルアミノな
どのC アルキルアミノ基;ジメチル1〜4
アミノ、ジエチルアミノおよびメチルエチルアミノなど
のジーC アルキルアミノ基;並びに1〜4
トリメチルアンモニオおよびトリエチルアンモニ・
オなどのトリーC アルキルアンモニオ基な1 〜
4
どから選ばれる1つ以上の置換基で置換されていてもよ
い。Further, as the acyl group in R2, for example, C2
~2o aliphatic acyl groups, such as acetyl, propionyl, butyryl, isobutyryl, isovaleryl, pivaloyl, lauroyl, balmitoyl and stearoyl, C alkenoyl groups such as acryloyl, propioloyl, etc. C-alkynoyl groups and C-cycloalkylcarbonyl groups such as cyclopropylcarbonyllohexylcarbonyl; aroyl groups such as benzoyl and naphthoyl; and nicotinoyl, isonicotinoyl,
Included are groups such as 5- or 6-membered heterocyclic carbonyl groups such as 1,4-dihydropyridylcarbonyl, prolyl, thenoyl and furoyl, which include C1-4 carbonyl groups such as methyl, ethyl, n-propyl and isopropyl.
Alkyl groups; C cycloalkyl groups such as cyclopropyl, cyclobutyl and cyclohexyl; C alkoxy groups such as methoxy, 3-7 ethoxy, n-propoxy and isopropoxy; C with isopropylthio alkylthio group niacetyloxy, 1-4 C with propionyloxy and butyryloxy
Acyloxy group; C alkylenedioxy group such as methylenedioxy and 2-4 and ethylenedioxy; hydroxyl group; aryl group such as phenyl, 3-nitrophenyl and naphthyl; carboxyl group; methoxycarbonyl and ethoxycarbonyl C alkoxycarboxyl groups such as 1-4 nyl groups; amino groups; C alkylamino groups such as methylamino and ethylamino; dimethyl 1-4 amino groups such as diethylamino, diethylamino and methylethylamino; and 1-4 trimethyl Ammonio and triethyl ammonium
Tri-C such as O, alkyl ammonio group 1 ~
4. May be substituted with one or more substituents selected from.
これらのうち、ヒドロキシル基、カルボキシル基、アミ
ノ基およびアルキルアミノ基などは、たとえば、プロテ
クテイブ・グループス・イン・オーガニック・シンセシ
ス(Protective Groups inOrg
anic Synthesis) [セオドラ・ダブ
リュー・グリーン(Theodra W.Green)
、ジョン・ウィリー・アンド・サンズ・インコーホレイ
テッド( JohnWi Iey & Sons. I
nc. )]などに記載された通常の保護基で保護され
ていてもよい。Among these, hydroxyl groups, carboxyl groups, amino groups, alkylamino groups, etc.
anic Synthesis) [Theodora W. Green]
, John Wiley & Sons, Inc.
nc. )] may be protected with a conventional protecting group such as those described in .
つぎに、一般式[I]の化合物の製造法について説明す
る。Next, a method for producing the compound of general formula [I] will be explained.
製法(1)
一般式[I]の化合物は、一般式[II]R1−OH’
[R1
[式中、R1は前記したと同様の意味を有する。]
で表わされる化合物またはその塩に、一般式[m]R−
−0w1 [111]「式中、R−は前記
したと同様の意味を有する。」
で表わされる化合物またはそのカルボキシル基における
反応性誘導体を反応させることによって得ることができ
る。Production method (1) The compound of general formula [I] has the general formula [II] R1-OH'
[R1 [wherein, R1 has the same meaning as described above]. ] The compound or its salt represented by the general formula [m]R-
-0w1 [111] "In the formula, R- has the same meaning as defined above." It can be obtained by reacting a compound represented by the following or a reactive derivative thereof in the carboxyl group.
一般式[ff]の化合物における塩としては、たとえば
、ナトリウムおよびカリウムなどのアルカリ金属との塩
などが挙げられる。Examples of the salt of the compound of general formula [ff] include salts with alkali metals such as sodium and potassium.
また、一般式[111]の化合物のカルボキシル基にお
ける反応性誘導体としては、たとえば、酸ハライド、活
性酸アミド、活性エステル、酸無水物および混合酸無水
物などが挙げられる。Further, examples of reactive derivatives at the carboxyl group of the compound of general formula [111] include acid halides, active acid amides, active esters, acid anhydrides, and mixed acid anhydrides.
一般式[I[1]の化合物を用いる場合、ジシクロヘキ
シルカルボジイミドなどの通常の脱水縮合剤を使用する
ことが好ましく、また、一般式[111]の化合物のカ
ルボキシル基における反応性誘導体を用いる場合、水素
化ナトリウム、ごリジンおよびトリエチルアミンなどの
無機または有機塩基を使用することが好ましい。When using the compound of general formula [I[1], it is preferable to use a common dehydration condensation agent such as dicyclohexylcarbodiimide, and when using a reactive derivative in the carboxyl group of the compound of general formula [111], hydrogen Preference is given to using inorganic or organic bases such as sodium chloride, lysine and triethylamine.
この反応は、溶媒中で行ってもよく、使用される溶媒と
しては、反応に悪影響を及ぼさないものであれば特に限
定されないが、たとえば、ベンゼンおよびトルエンなど
の芳香族炭化水素類;塩化メチレンおよびクロロホルム
などのハロゲン化炭化水素類:テトラヒドロフランおよ
びジオキサンなどのエーテル類:ピリジン;ヘキサメチ
ルホスホリックトリアミド、N、N−ジメチルホルムア
ミドおよびN、N−ジメチルアセトアミドなどのアミド
類;並びにジメチルスルホキシドなどのスルホキシド類
などが挙げられ、これらの溶媒を一種または二種以上混
合して使用してもよい。This reaction may be carried out in a solvent, and the solvent used is not particularly limited as long as it does not adversely affect the reaction, but examples include aromatic hydrocarbons such as benzene and toluene; methylene chloride and Halogenated hydrocarbons such as chloroform; ethers such as tetrahydrofuran and dioxane; pyridine; amides such as hexamethylphosphoric triamide, N,N-dimethylformamide and N,N-dimethylacetamide; and sulfoxides such as dimethylsulfoxide. These solvents may be used alone or in combination of two or more.
この反応において、一般式[II[]の化合物またはそ
のカルボキシル基における反応性誘導体の使用量は、一
般式[nlの化合物またはその塩に対して、等モル以上
であり、また、脱水縮合剤または塩基を使用する場合、
脱水縮合剤または塩基の使用量は、一般式[I[]の化
合物またはその塩に対して、それぞれ等モル以上である
。In this reaction, the amount of the compound of general formula [II[] or its reactive derivative at the carboxyl group to be used is at least equimolar to the compound of general formula [nl] or its salt, and the amount of the dehydration condensing agent or When using bases,
The amount of the dehydration condensation agent or base to be used is at least equimolar to the compound of general formula [I[] or its salt.
この反応は、通常、0〜80℃で、10分〜10時間実
施すればよい。This reaction may normally be carried out at 0 to 80°C for 10 minutes to 10 hours.
製法(2)
一般式[IIの化合物は、一般式[IV]R’−X
[IV]
「式中、R1は前記したと同様の意味を有し、Xは脱離
基を示す。」
で表わされる化合物に、一般式[m]で表わされる化合
物の塩を反応させることによって得ることができる。Production method (2) The compound of the general formula [II is the compound of the general formula [IV]R'-X
[IV] By reacting a salt of a compound represented by the general formula [m] with a compound represented by "In the formula, R1 has the same meaning as described above, and X represents a leaving group." Obtainable.
一般式[IV]の化合物において、Xにおける脱離基と
しては、たとえば、フッ素、塩素、臭素およびヨウ素な
どのハロゲン原子:メタンスルホニルオキシおよびエタ
ンスルホニルオキシなどのC1〜4アルカンスルホニル
オキシ基;またはトルエンスルホニルオキシおよびベン
ゼンスルホニルオキシなどのアレーンスルホニルオキシ
基などが挙げられる。In the compound of general formula [IV], the leaving group for X includes, for example, a halogen atom such as fluorine, chlorine, bromine, and iodine; a C1-4 alkanesulfonyloxy group such as methanesulfonyloxy and ethanesulfonyloxy; or toluene Examples include arenesulfonyloxy groups such as sulfonyloxy and benzenesulfonyloxy.
一般式[I[[]の化合物における塩としては、ナトリ
ウムおよびカリウムなどのアルカリ金属との塩などが挙
げられる。Examples of the salts of the compound of general formula [I[] include salts with alkali metals such as sodium and potassium.
この反応は、溶媒中で行ってもよく、使用される溶媒と
しては、反応に悪影響を及ぼさないものであれば特に限
定されないが、具体的には、前記製法(1)で挙げたと
同様の溶媒が挙げられる。This reaction may be carried out in a solvent, and the solvent used is not particularly limited as long as it does not adversely affect the reaction, but specifically, the same solvents as mentioned in the above production method (1) can be used. can be mentioned.
この反応において、一般式[I[1]の化合物の塩の使
用量は、一般式[IV]の化合物に対して、等モル以上
である。In this reaction, the amount of the salt of the compound of general formula [I[1] to be used is equal to or more than the equivalent mole of the compound of general formula [IV].
この反応は、通常、−70〜150℃で、10分〜20
時間実施すればよい。This reaction is usually carried out at -70 to 150°C for 10 to 20 minutes.
All you have to do is time it.
上記製法(1)または製法(2)で得られた化合物は、
通常の方法で保護基を脱離させた後、カラム分離および
蒸留などの通常の手段により精製できる。The compound obtained by the above production method (1) or production method (2) is
After removing the protecting group by conventional methods, it can be purified by conventional means such as column separation and distillation.
また、一般式[IIの化合物またはその塩において、異
性体(たとえば、光学異性体、幾何異性体、互変異性体
など)が存在する場合、本発明は、それらすべての異性
体を包含し、またすべての結晶形および溶媒和物におよ
ぶものである。In addition, when isomers (e.g., optical isomers, geometric isomers, tautomers, etc.) exist in the compound of general formula [II or a salt thereof, the present invention includes all such isomers, It also covers all crystal forms and solvates.
本発明の養毛剤(全重量)中における一般式[I]の化
合物の含有量は、とくに限定されず広範囲に選択するこ
とができるが、通常、0.1〜10重借%、好ましくは
、0.5〜5重但%であればよい。The content of the compound of general formula [I] in the hair nourishing agent (total weight) of the present invention is not particularly limited and can be selected within a wide range, but is usually 0.1 to 10%, preferably 0. It is sufficient if it is .5 to 5%.
本発明の養毛剤には、その作用をそこなわない限り、従
来養毛剤に使用されているアミノ酸類(セリン、メチオ
ニンなど)、ホルモン剤(プロゲステロン、エストラジ
オールなど)、抗炎症剤(紫根エキス、グリチルリチン
酸、酢酸ヒドロコルチゾンなど)、血管拡張剤にコチン
酸、ミノキシジルなど)、生薬エキス類(センブリエキ
ス、ニンジンエキスなど)、ふけ防止剤(ヒノキチオー
ル、イオウなと)、清涼剤(1−メントール、カンフル
など)、湿潤剤(グリセリン、ムコ多糖類、ピロリドン
カルボン酸など)、角質溶解剤(尿素、レゾルシンなど
)、香料(ラベンダーオイル、ネロリ、ベルガモツトな
ど・)、ビタミンA、ビタミンEまたはビタミンE誘導
体、ビタミンB6、ビタミンH、レシチンおよび脂肪酸
類などを一種または二種以上添加して使用することがで
きる。The hair tonic of the present invention includes amino acids (serine, methionine, etc.), hormonal agents (progesterone, estradiol, etc.), anti-inflammatory agents (purple root extract, glycyrrhizinic acid, hydrocortisone acetate, etc.), vasodilators such as cotinic acid, minoxidil, etc.), herbal extracts (Japanese cabbage extract, carrot extract, etc.), anti-dandruff agents (hinokitiol, sulfur nato), cooling agents (1-menthol, camphor, etc.), Humectants (glycerin, mucopolysaccharides, pyrrolidone carboxylic acid, etc.), keratolytic agents (urea, resorcinol, etc.), fragrances (lavender oil, neroli, bergamot etc.), vitamin A, vitamin E or vitamin E derivatives, vitamin B6, Vitamin H, lecithin, fatty acids, etc. can be used singly or in combination of two or more.
また、基剤としては、たとえば、精製水、−価アルコー
ル類(エタノール、イソプロピルアルコールなど)、多
価アルコール類(グリセリン、プロピレングリコールな
と)、高級脂肪酸類(パルミチン酸、リノール酸など)
、油脂類(脂肪酸グリセライド、オリーブ油、スクリー
ン、ミツロウなど)、流動パラフィン、界面活性剤(ポ
リオキシエチレン硬化ヒマシ油、塩化ステアリルトリメ
チルアンモニウム、塩化ジステアリルジメチルアンモニ
ウム、ラウリルra酸ナトリウムなど)、乳化剤(セチ
ルアルコール)および可溶化剤などを使用することがで
きる。Examples of base materials include purified water, -hydric alcohols (ethanol, isopropyl alcohol, etc.), polyhydric alcohols (glycerin, propylene glycol, etc.), higher fatty acids (palmitic acid, linoleic acid, etc.)
, fats and oils (fatty acid glycerides, olive oil, screens, beeswax, etc.), liquid paraffin, surfactants (polyoxyethylene hydrogenated castor oil, stearyltrimethylammonium chloride, distearyldimethylammonium chloride, sodium lauryl raate, etc.), emulsifiers (cetyl alcohol) and solubilizers, etc. can be used.
本発明の養毛剤は、常法にしたがって、ヘアトニック、
ヘアクリーム、ヘアローションまたはヘアスプレーなど
の種々の剤形に調製して用いることができる。The hair tonic of the present invention can be prepared by a conventional method such as a hair tonic,
It can be prepared and used in various dosage forms such as hair cream, hair lotion, or hair spray.
つぎに本発明の養毛剤の効果を説明する。Next, the effects of the hair tonic of the present invention will be explained.
(発毛促進効果試験)
6週齢のBDFl、雄マウス4匹を一群とし、背部から
でん部を安全カミソリで刺毛し、翌日から発毛を抑制す
る目的で、2%(重量化)のテストステロンを含むエタ
ノール溶液0.2 m/マウスを1日1回、1週間にわ
たり塗布した。刺毛8臼目からは、同量を2回/週の割
合で3週間にわたり塗布した。(Hair growth promotion effect test) A group of 4 6-week-old BDFL male mice were pricked from the back to the buttocks with a safety razor, and from the next day, 2% (weighted) was used to suppress hair growth. An ethanol solution containing 0.2 m/mouse of testosterone was applied once a day for 1 week. From the 8th molar onwards, the same amount was applied twice/week for 3 weeks.
一方、試験液剤は刺毛8臼目から0.2 Idt/マウ
スを1日1回、3週間(日曜日を除く)にわたり塗布し
た。また、対照群には、エタノール85.5重量部、グ
リセリンio、 o重量部および精製水4.5重量部か
らなる液(以下、混合液Aと略記する。)0.2m/マ
ウスを刺毛8臼目から1日1回、3週間(日曜日を除く
)にわたり塗布した。On the other hand, the test solution was applied once a day for 3 weeks (excluding Sundays) at a rate of 0.2 Idt/mouse from the 8th molar of the hair. In addition, for the control group, a solution (hereinafter abbreviated as mixed solution A) consisting of 85.5 parts by weight of ethanol, io, and 4 parts of glycerin, and 4.5 parts by weight of purified water (hereinafter abbreviated as mixed solution A) was applied to 0.2 m/mouse by pricking. It was applied once a day from the 8th mound for 3 weeks (excluding Sundays).
本発明の新規な養毛剤による発毛促進効果は、毛の成長
程度を毎日肉眼で観察し、刺毛部位の全面に発毛したマ
ウスの四散で判定した。The hair growth promoting effect of the novel hair growth agent of the present invention was determined by observing the degree of hair growth with the naked eye every day and measuring the size of mice that had hair growth on the entire surface of the stinging site.
なお、表−1においては、試験液剤を投与してから2週
問および3週間経過後に観察した発毛促進効果を下のよ
うに、
発毛したマウスの四散
発毛促進効果=
試験マウスの四散
で示す。In addition, in Table 1, the hair growth promoting effect observed 2 weeks and 3 weeks after administration of the test solution is shown below. Indicated by
また、試験液剤は、参考側番号で示した化合物を表−1
に示した′a度で混合液Aに混合し、調製したものを用
いた。In addition, the test solution is the compound indicated by the reference side number in Table 1.
The mixture prepared by mixing with liquid mixture A at the temperature shown in 1 was used.
(以下余白)
表−1
*1−ペンタデカノイルグリセロール
本*混合液Aに対する重量比
この結果から明らかなように、本発明の養毛剤は優れた
発毛促進効果を発揮する。(The following is a blank space) Table 1 *1-Pentadecanoylglycerol book *Weight ratio to mixture A As is clear from these results, the hair growth agent of the present invention exhibits an excellent hair growth promoting effect.
[発明の効果]
本発明の一般式
%式%
「式中、R およびR2は前記したと同様の意味を有す
る。」
で表わされる化合物は、養毛剤として利用できる。[Effects of the Invention] The compound of the present invention represented by the general formula % "In the formula, R and R2 have the same meanings as described above" can be used as a hair nourishing agent.
つぎに、本発明の一般式[I]で表わされる化合物の製
法を具体的に参考例を挙げて説明する。Next, the method for producing the compound represented by the general formula [I] of the present invention will be specifically explained by giving reference examples.
なお、混合溶媒の混合比は、すべて容量比であり、カラ
ムクロマトグラフィーにおける担体は、特に断わらない
かぎり、メルク社製のシリカゲル[キーセルゲル60,
アート、 7734(にieselgel 60。All mixing ratios of mixed solvents are volume ratios, and the carrier in column chromatography is silica gel manufactured by Merck [Kiesel Gel 60,
Art, 7734 (in ieselgel 60.
Art.7734 ) ]を用いた。Art. 7734)] was used.
参考例1
フィトール10.0gおよびトリエチルアミン9.03
を含む塩化メチレン50mの混合液にニコチン酸クロリ
ド7、29を30〜40℃で添加し、得られた混合物を
同温度で2時間撹拌する。反応終了後、反応混合物を希
塩酸、3%炭酸水素ナトリウム水溶液および水で順次洗
浄した後、無水硫酸マグネシウムで乾燥させる。減圧下
に溶媒を留去し、iqられた残留物をカラムクロマトグ
ラフィー(溶離液;n−ヘキサン:酢酸エチル=9 :
1 )で精製すれば、油状のニコチン酸フィチル12
.1g(収率90%)を得る。Reference example 1 phytol 10.0g and triethylamine 9.03
Nicotinic acid chloride 7, 29 is added to a mixed solution of 50 ml of methylene chloride containing the following at 30 to 40°C, and the resulting mixture is stirred at the same temperature for 2 hours. After the reaction is completed, the reaction mixture is washed successively with dilute hydrochloric acid, a 3% aqueous sodium bicarbonate solution, and water, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the iq residue was subjected to column chromatography (eluent: n-hexane: ethyl acetate = 9:
If purified by 1), oily phytyl nicotinate 12
.. 1 g (90% yield) is obtained.
IRにート) cm−1: 2920, 2850.
1725N)IR(CDCl2)δ値;
0、86(12H,d,J=5.5Hz)、0.99〜
1.65(1911,m)。IR) cm-1: 2920, 2850.
1725N) IR (CDCl2) δ value; 0, 86 (12H, d, J = 5.5Hz), 0.99 ~
1.65 (1911, m).
1、 76(3H, s) 、 1. 70 〜2.
25 (2H, m) 。1, 76 (3H, s), 1. 70 ~2.
25 (2H, m).
4、87(2H,d,J=7.0Hz)、5.48(l
tl, t,J=6.4Hz)。4, 87 (2H, d, J = 7.0Hz), 5.48 (l
tl, t, J=6.4Hz).
7、 33, 7. 40(IH, dd, J=7.
9Hz, J=4. 6Hz) 。7, 33, 7. 40 (IH, dd, J=7.
9Hz, J=4. 6Hz).
8、 22, 8. 35(IH,dt, J=4.
6tlZ, J=1.9Hz) 。8, 22, 8. 35 (IH, dt, J=4.
6tlZ, J=1.9Hz).
8、 74, 8. 77(11, dd, J=4.
6Hz, J=1. 9Hz) 。8, 74, 8. 77 (11, dd, J=4.
6Hz, J=1. 9Hz).
9、 23(1H, d, J=1. 9Hz)同様に
して、表−2の化合物を得る。9, 23 (1H, d, J=1.9Hz) In the same manner, the compounds shown in Table 2 are obtained.
参考例19
フィトール10.09tjよびトリエチルアミン4.5
3を含む塩化メチレン30dの混合液にクロロアセチル
マンデル酸クロリド10.0gを含む塩化メチレン溶液
10dを30〜40℃で滴下し、得られた混合物を同温
度で2時間撹拌する。反応終了後、反応混合物を希塩酸
、3%炭酸水素ナトリウム水溶液および水で順次洗浄す
る。減圧下に溶媒を留去し、得られた残留物をメタノー
ル50m1に溶解させた後、これに空温でトリエチルア
ミン3.8ヒおよびチオ尿素2.97を添加し、得られ
た混合物を同温度で3時間撹拌する。反応終了後、減圧
下に反応混合物を濃縮乾固し、得られた残留物を酢酸エ
チルに溶解させる。この溶液を希塩酸、3%炭酸水素ナ
トリウム水溶液および水で順次洗浄した後、無水硫酸マ
グネシウムで乾燥させる。減圧下に溶媒を留去し、得ら
れた残留物をカラムクロマトグラフィー(溶離液;n−
ヘキサン:酢酸エチル=9 : 1 )で精製すれば、
油状のマンデル酸フィチル13.(IJ(収率90%)
を得る。Reference example 19 Phytol 10.09tj and triethylamine 4.5
10 d of a methylene chloride solution containing 10.0 g of chloroacetylmandelic acid chloride is added dropwise to a mixed solution of 30 d of methylene chloride containing 3 at 30 to 40° C., and the resulting mixture is stirred at the same temperature for 2 hours. After the reaction is completed, the reaction mixture is washed successively with dilute hydrochloric acid, 3% aqueous sodium bicarbonate solution, and water. The solvent was distilled off under reduced pressure, and the resulting residue was dissolved in 50 ml of methanol. 3.8 ml of triethylamine and 2.97 ml of thiourea were added thereto at air temperature, and the resulting mixture was heated at the same temperature. Stir for 3 hours. After the reaction is completed, the reaction mixture is concentrated to dryness under reduced pressure, and the resulting residue is dissolved in ethyl acetate. This solution is washed successively with dilute hydrochloric acid, a 3% aqueous sodium bicarbonate solution, and water, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was subjected to column chromatography (eluent: n-
If purified with hexane:ethyl acetate=9:1),
Oily phytyl mandelate13. (IJ (yield 90%)
get.
IRに−ト) cm−1; 3500.2920.28
50.173ONMR(CDCl2 >δ値:
o、 8B(12H,d、 J=5.5Hz) 、 0
.99〜1.55 (191L m)。IR) cm-1; 3500.2920.28
50.173ONMR (CDCl2 > δ value: o, 8B (12H, d, J=5.5Hz), 0
.. 99-1.55 (191 L m).
1、60(3H,S)、 1.70〜2.20(2H,
m) 。1, 60 (3H, S), 1.70-2.20 (2H,
m).
3.64(ltl、bs)、4.64(21,d、J=
7.3Hz)。3.64 (ltl, bs), 4.64 (21, d, J=
7.3Hz).
5、14(1H,s) 、 5.27(IH,t、 J
=7.0Hz) 。5, 14 (1H, s), 5.27 (IH, t, J
=7.0Hz).
7、10〜7.55(5H,m) 参考例20 参考例19と同様にして、乳酸フィチルを得る。7, 10-7.55 (5H, m) Reference example 20 Phytyl lactate is obtained in the same manner as in Reference Example 19.
IRに−ト) cm−1: 3450,2920,28
60.173ON)IR(CDCl2 )δ値;
0.86(1211,d、J=5.4Hz)、1.00
〜1.60(22H,m)。IR) cm-1: 3450, 2920, 28
60.173ON) IR (CDCl2) δ value; 0.86 (1211, d, J=5.4Hz), 1.00
~1.60 (22H, m).
1.69(311,s)、1.85〜2.30(211
,m)。1.69 (311,s), 1.85-2.30 (211,s)
, m).
4、10〜4.50(IH,m)、 4.68(2H,
d、 J=6.8tlz)。4, 10-4.50 (IH, m), 4.68 (2H,
d, J=6.8tlz).
5、35 (111,t、 J=6.8H2)参考例2
1
ニコチン酸ナトリウム6.4gを含むN、N−ジメチル
ホルムアミド40mの混合液にブロモフィチル10.0
gを添加し、得られた混合物を60’Cで15時間攪拌
する。反応終了後、減圧下にこの反応混合物を濃縮し、
得られた残留物をn−ヘキサンに溶解させる。この溶液
を希塩酸、3%炭酸水素ナトリウム水溶液および水で順
次洗浄した後、無水硫酸マグネシウムで乾燥させる。減
圧下に溶媒を留去し、得られた残留物をカラムクロマト
グラフィー(溶離液;n−ヘキサン:酢酸エチル=9:
1)で精製すれば、油状のニコチン酸フィチル8.4g
(収率75%)を得る。5, 35 (111,t, J=6.8H2) Reference example 2
1 Add 10.0 bromophytyl to a mixture of 40 m of N,N-dimethylformamide containing 6.4 g of sodium nicotinate.
g is added and the resulting mixture is stirred at 60'C for 15 hours. After the reaction is complete, concentrate the reaction mixture under reduced pressure,
The resulting residue is dissolved in n-hexane. This solution is washed successively with dilute hydrochloric acid, a 3% aqueous sodium bicarbonate solution, and water, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was subjected to column chromatography (eluent: n-hexane: ethyl acetate = 9:
If purified by 1), 8.4 g of oily phytyl nicotinate
(yield 75%).
この化合物の物性(IR,NMR)は参考例1で得られ
た化合物の物性と一致した。The physical properties (IR, NMR) of this compound matched those of the compound obtained in Reference Example 1.
参考例22 N−7セチルグリシン4.749および4− (N。Reference example 22 N-7 cetylglycine 4.749 and 4-(N.
N−ジメチルアミン)ピリジン12.369を含む塩化
メチレン70dの混合液を一50℃に冷却し、これにメ
タンスルホニルクロリド4.259を滴下する。A mixed solution of 70 d of methylene chloride containing 12.369 d of N-dimethylamine)pyridine is cooled to -50 DEG C., and 4.259 d of methanesulfonyl chloride is added dropwise thereto.
滴下終了後、得られた混合物を同温度で1時間撹拌し、
これにフィトールio、oo gを同温度で滴下する。After the addition was completed, the resulting mixture was stirred at the same temperature for 1 hour,
Phytol io and oo g are added dropwise to this at the same temperature.
滴下終了後、6時間を要して反応混合物の温度を室温ま
で昇温させる。ついで、反応混合物を2N塩酸、3%炭
酸水素ナトリウム水溶液および水で順次洗浄した後、無
水硫酸マグネシウムで乾燥させる。減圧下に溶媒を留去
し、得られた残留物をカラムクロマトグラフィー(溶離
液;クロロホルム)で精製すれば、油状のN−アセチル
グリシルフィチル12.00 g(収率90.2%)を
得る。After the dropwise addition is completed, the temperature of the reaction mixture is raised to room temperature over a period of 6 hours. The reaction mixture is then washed successively with 2N hydrochloric acid, 3% aqueous sodium bicarbonate solution and water, and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and the resulting residue was purified by column chromatography (eluent: chloroform) to obtain 12.00 g of oily N-acetylglycylphityl (yield 90.2%). obtain.
IRに−ト) cm−1: 32B0.2920.28
60.1747゜開鎖CDCl3>δ値;
0.86(12H,d、J=5.5112)、 1.0
0〜1.60(191,m)。IR) cm-1: 32B0.2920.28
60.1747° Open chain CDCl3>δ value; 0.86 (12H, d, J=5.5112), 1.0
0-1.60 (191, m).
1.69(3H,S)、1.85〜2.30(5N、m
)。1.69 (3H, S), 1.85-2.30 (5N, m
).
4、01 (2H,d、 J=4.9Hz) 、 4.
66(2H,d、 J=7.311z) 。4, 01 (2H, d, J=4.9Hz), 4.
66 (2H, d, J=7.311z).
5.39(IH,t、 J=7.1Hz)、 6.23
(IH,bs)同様にして、表−3の化合物を得る。5.39 (IH, t, J=7.1Hz), 6.23
(IH, bs) Compounds shown in Table 3 are obtained in the same manner.
(以下余白)
参考例27
N−トリクロロエトキシカルボニルグリシン5.0(I
Jおよび4− (N、N−ジメチルアミノ)ピリジン8
.109を含む塩化メチレン35威の混合液を一50℃
に冷却し、これにメタンスルホニルクロリド2.10!
7を滴下する。滴下終了後、得られた混合物を同温度で
1時間撹拌し、これにフィトール4.939を同温度で
滴下する。滴下終了後、6時間を要して反応混合物の温
度を室温まで昇温させる。(Left below) Reference Example 27 N-trichloroethoxycarbonylglycine 5.0 (I
J and 4-(N,N-dimethylamino)pyridine 8
.. A mixture of 35 parts of methylene chloride containing 109 was heated to -50°C.
Cool to 2.10% of methanesulfonyl chloride!
Drip 7. After the dropwise addition is completed, the resulting mixture is stirred at the same temperature for 1 hour, and Phytol 4.939 is added dropwise thereto at the same temperature. After the dropwise addition is completed, the temperature of the reaction mixture is raised to room temperature over a period of 6 hours.
ついで、反応混合物を2N塩酸、3%炭酸水素ナトリウ
ム水溶液および水で順次洗浄した後、無水硫酸マグネシ
ウムで乾燥させる。減圧下に溶媒を留去し、得られた残
留物をテトラヒドロフラン86dに溶解させる。この溶
液に0.5N第一リン酸カリウム水溶液86dおよび粉
末亜鉛13.409を添加し、得られた混合物を室温で
2時間撹拌する。ついで、反応混合物を濾過し、減圧下
に炉液を濃縮し、得られた残留物に酢酸エチル30m1
を添加し、これを2N塩酸で洗浄した後、無水硫酸マグ
ネシウムで乾燥させる。この溶液に塩化水素ガスを導入
した後、得られた溶液から減圧下に溶媒を留去すれば、
油状のグリシルフィチルの塩酸塩5.809(収率90
%)を得る。The reaction mixture is then washed successively with 2N hydrochloric acid, 3% aqueous sodium bicarbonate solution and water, and then dried over anhydrous magnesium sulfate. The solvent is distilled off under reduced pressure, and the resulting residue is dissolved in tetrahydrofuran 86d. To this solution are added 86d of 0.5N aqueous monobasic potassium phosphate solution and 13.409d of powdered zinc, and the resulting mixture is stirred at room temperature for 2 hours. Then, the reaction mixture was filtered, the filtrate was concentrated under reduced pressure, and 30 ml of ethyl acetate was added to the resulting residue.
is added, washed with 2N hydrochloric acid, and then dried over anhydrous magnesium sulfate. After introducing hydrogen chloride gas into this solution, the solvent is distilled off from the resulting solution under reduced pressure.
Oily glycylphityl hydrochloride 5.809 (yield 90
%).
IRに−ト) cm−1; 3400.2920.28
60.1745N)IR(CDCl2>δ値;
0、86(12H,d、 J=5.5Hz)、 1.0
0〜1.60(19H,m) 。IR) cm-1; 3400.2920.28
60.1745N) IR (CDCl2>δ value; 0, 86 (12H, d, J=5.5Hz), 1.0
0-1.60 (19H, m).
1.68(311,S)、 1.95〜2.12(2N
、m)。1.68 (311,S), 1.95~2.12 (2N
, m).
3、99(2tl、、s)、 4.61 (2H,d、
J=6.6Hz) 。3,99 (2tl,,s), 4.61 (2H,d,
J=6.6Hz).
5、30(IH,t、J=6.6112)参考例28
参考例27と同様にして、叶−バリルフィチルの塩酸塩
を得る。5, 30 (IH, t, J=6.6112) Reference Example 28 In the same manner as in Reference Example 27, the hydrochloride of baryl phytyl is obtained.
IRに−ト) cm−1; 2910.2850.17
3ONHR(CDCl2 )δ値;
0.50〜1.05(18H,m)、1.05〜1.6
0(19H,m)。IR) cm-1; 2910.2850.17
3ONHR (CDCl2) δ value; 0.50-1.05 (18H, m), 1.05-1.6
0 (19H, m).
1、71 (3H,m)、 1.82〜2.50(3+
1. m)。1,71 (3H,m), 1.82~2.50 (3+
1. m).
4、00(IH,s)、 4.70(2N、 d、 J
=7.0Hz)。4,00(IH,s), 4.70(2N, d, J
=7.0Hz).
5、32(IH,t、J=7.0H7)、8.30(2
N、 S)参考例29
N、N−ジメチルグリシルフィチル10.Ogを含む塩
化メチレン30m1の混合液にヨウ化メチル4.53を
添加し、得られた混合物を室温で1時間撹拌する。反応
終了後、減圧下に溶媒を留去すれば、油状のα−トリメ
チルアンモニオ酢酸フィチルヨーシト12g(収率88
%)を得る。5, 32 (IH, t, J = 7.0H7), 8.30 (2
N, S) Reference Example 29 N, N-dimethylglycylphityl 10. 4.53 ml of methyl iodide is added to a mixture of 30 ml of methylene chloride containing Og, and the resulting mixture is stirred at room temperature for 1 hour. After the reaction is completed, the solvent is distilled off under reduced pressure to obtain 12 g of oily α-trimethylammonioacetic acid phytyl ioside (yield: 88
%).
IRに−ト) cm−1: 2910.2850.17
35NMR(CDCl2>δ値:
0、89(12H,d、 J=5.5NZ)、 1.0
0〜1.65(19H,m)。IR) cm-1: 2910.2850.17
35NMR (CDCl2>δ value: 0, 89 (12H, d, J=5.5NZ), 1.0
0-1.65 (19H, m).
1、71 (3H,s) 、 1.90〜2.30(2
H,m)。1,71 (3H,s), 1.90-2.30 (2
H, m).
3゜74(9N、s)、4.70〜5.10(4H,m
)。3°74 (9N, s), 4.70~5.10 (4H, m
).
5、34(1M、 t、J=6. IHz)参考例30
フィトールio、o9を含む酢950rdlの混合液に
シアン酸ナトリウム6.63を少量ずつ添加し、得られ
た混合物を室温で6時間撹拌する。反応終了後、減圧下
に反応混合物を濃縮し、得られた残留物を酢酸エチル5
0trriに溶解させる。この溶液を3%炭酸水素ナト
リウム水溶液および水で順次洗浄した後、無水硫酸マグ
ネシウムで乾燥させる。減圧下にこの溶液を濃縮し、得
られた残留物をカラムクロマトグラフィー(溶離液;ベ
ンゼン)で精製すれば、油状のカルバミン酸フィチル1
0.09(収率87%)を得る。5, 34 (1M, t, J = 6. IHz) Reference Example 30 6.63 ml of sodium cyanate was added little by little to a mixture of 950 rdl of vinegar containing phytol io, o9, and the resulting mixture was kept at room temperature for 6 hours. Stir. After the reaction was completed, the reaction mixture was concentrated under reduced pressure, and the resulting residue was diluted with ethyl acetate (55%).
Dissolve to 0 tri. This solution is washed successively with a 3% aqueous sodium bicarbonate solution and water, and then dried over anhydrous magnesium sulfate. This solution is concentrated under reduced pressure, and the resulting residue is purified by column chromatography (eluent: benzene) to obtain oily phytyl carbamate 1.
0.09 (yield 87%) is obtained.
IR(ニーI” ) cm−1; 3320.2910
.2850.172ON)fR(CDCl2>δ値:
0.86(12H,d、J=5.5Hz)、 1.00
〜1.60(19H,m)。IR (knee I”) cm-1; 3320.2910
.. 2850.172ON) fR (CDCl2>δ value: 0.86 (12H, d, J=5.5Hz), 1.00
~1.60 (19H, m).
1、73(3N、 m)、 1.80〜2.30(2H
,m)。1,73 (3N, m), 1.80-2.30 (2H
, m).
4、57(2H,d、 J=7.0Hz) 、 5.3
4(IH,d、 J=7.0tlz)[実施例]
つぎに、本発明の実施例として、本発明の養毛剤の種々
の剤形をその組成(重量%)とともに示すが、本発明は
、これらに限定されるものではない。4, 57 (2H, d, J=7.0Hz), 5.3
4 (IH, d, J=7.0tlz) [Example] Next, as an example of the present invention, various dosage forms of the hair tonic of the present invention are shown together with their compositions (% by weight). It is not limited to these.
実施例1(ヘアローション)
(成分) 含M(重量%)
L精製水 11.4実施例2(
ヘア口、−ジョン)
(成分) 含量(重量%)
実施例3(ヘアクリーム)
(成分) 含量(重量%)
実施例4(ヘアリンス)
(成分) 含量(重量%)Example 1 (hair lotion) (Ingredients) M content (wt%) L Purified water 11.4 Example 2 (
(Ingredients) Content (wt%) Example 3 (hair cream) (Ingredients) Content (wt%) Example 4 (hair rinse) (Ingredients) Content (wt%)
Claims (1)
い炭素数20の非環式分岐状高級脂肪族炭化水素基を;
R^2はアシル基を示す。」 で表わされる化合物を有効成分とする養毛剤。(1) General formula R^1-O-R^2 "In the formula, R^1 is an acyclic branched higher aliphatic hydrocarbon group having 20 carbon atoms which may be substituted with an acyloxy group;
R^2 represents an acyl group. A hair tonic containing a compound represented by the following as an active ingredient.
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1813489A JP2819415B2 (en) | 1988-06-03 | 1989-01-27 | Hair restorer |
GB8903335A GB2216003B (en) | 1988-02-18 | 1989-02-14 | Hair restorer |
AU29953/89A AU619247B2 (en) | 1988-02-18 | 1989-02-15 | Hair-restorer and process for hair growth |
CA000591244A CA1339196C (en) | 1988-02-18 | 1989-02-16 | Hair-restorer and process for hair growth |
DE3904751A DE3904751C2 (en) | 1988-02-18 | 1989-02-16 | Use of derivatives of higher alcohols for hair restoration |
NL8900396A NL8900396A (en) | 1988-02-18 | 1989-02-17 | HAIR REPAIR AND METHOD FOR PROMOTING HAIR GROWTH. |
IT8947664A IT1230477B (en) | 1988-02-18 | 1989-02-17 | Hair restorer compsns. |
FR8902101A FR2627384B1 (en) | 1988-02-18 | 1989-02-17 | HAIR REGENERATOR, TOPICAL COMPOSITION COMPRISING SAME, AND CORRESPONDING METHOD FOR GROWING HAIR AND HAIR |
SE8900567A SE8900567A0 (en) | 1988-02-18 | 1989-02-17 | Hair growth promoters and method of hair growth |
BE8900164A BE1004398A4 (en) | 1988-02-18 | 1989-02-17 | Regenerative hair, including topical composition and method for growing hair and hair. |
US07/311,945 US5236950A (en) | 1988-02-18 | 1989-02-17 | Process for hair growth |
CH563/89A CH678810A5 (en) | 1988-02-18 | 1989-02-17 | |
KR1019890001898A KR910004583B1 (en) | 1988-02-18 | 1989-02-18 | Hair tonic |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13682488 | 1988-06-03 | ||
JP63-136824 | 1988-06-03 | ||
JP1813489A JP2819415B2 (en) | 1988-06-03 | 1989-01-27 | Hair restorer |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0276804A true JPH0276804A (en) | 1990-03-16 |
JP2819415B2 JP2819415B2 (en) | 1998-10-30 |
Family
ID=26354764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1813489A Expired - Lifetime JP2819415B2 (en) | 1988-02-18 | 1989-01-27 | Hair restorer |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2819415B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006502213A (en) * | 2002-10-10 | 2006-01-19 | イエダ リサーチ アンド デベロップメント カンパニー リミテッド | Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulators |
JP2006045086A (en) * | 2004-08-02 | 2006-02-16 | Kanebo Cosmetics Inc | Hair tonic |
US7372351B2 (en) | 2006-06-20 | 2008-05-13 | Taiyo Yuden Co., Ltd. | Radial lead type inductor |
FR3110427A1 (en) * | 2020-05-20 | 2021-11-26 | Laboratoires Eriger | Coupling terpenic conjugate |
-
1989
- 1989-01-27 JP JP1813489A patent/JP2819415B2/en not_active Expired - Lifetime
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006502213A (en) * | 2002-10-10 | 2006-01-19 | イエダ リサーチ アンド デベロップメント カンパニー リミテッド | Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulators |
JP2006045086A (en) * | 2004-08-02 | 2006-02-16 | Kanebo Cosmetics Inc | Hair tonic |
US7372351B2 (en) | 2006-06-20 | 2008-05-13 | Taiyo Yuden Co., Ltd. | Radial lead type inductor |
FR3110427A1 (en) * | 2020-05-20 | 2021-11-26 | Laboratoires Eriger | Coupling terpenic conjugate |
WO2021240099A1 (en) * | 2020-05-20 | 2021-12-02 | Laboratoires Eriger | Coupled terpene conjugate |
Also Published As
Publication number | Publication date |
---|---|
JP2819415B2 (en) | 1998-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK172070B1 (en) | Benzonaphthalene derivatives, processes for their preparation and use, and their pharmaceutical and cosmetic preparations | |
JP3238944B2 (en) | Composition for suppressing hair thinning | |
EP0187854A1 (en) | Substituted pyrimidine oxides useful for hair growth promotion | |
EP0515982B1 (en) | Normal-pentadecyl nicotinate N-oxide and hair restorer comprising the same | |
EP0459890A1 (en) | Composition for use in preventing loss of hair and for inducing and stimulating its growth, containing derivatives of 2-alkyl-4-amino(or -2,4-dialkyl)-pyrimidin-3-oxide and the new derivatives of 2-alkyl-4-amino-pyrimidin-3-oxide | |
CA1339196C (en) | Hair-restorer and process for hair growth | |
JPH04164014A (en) | Hair cosmetic | |
JPH11228525A (en) | New compound derived from n-aryl-2-hydroxyalkylamide | |
JPH0276804A (en) | Hair tonic | |
JP2015502950A (en) | Novel adipogenesis inhibitor compounds | |
HAZIRI et al. | Anticoagulant activity of coumarin derivatives | |
KR19990023754A (en) | Quinazolinone derivatives and hair follicles, external skin preparations | |
WO1989006234A1 (en) | N,n-substituted amines and use thereof in hair growth promotion | |
EP3490549A1 (en) | Dermatological formulations of 2-(2-ethoxy-2-oxoethyl)(methyl)amino-2-oxoethyl 5-(tetradecyloxy)furan-2-carboxylate | |
KR20170011019A (en) | Manufacturing method of Pyridoxine derivatives combined with Ascorbic acid | |
JP3335641B2 (en) | 3-Aryl-2,4-dioxooxazolidine family compounds and their use in cosmetics and pharmaceuticals | |
JPS6157594A (en) | Galactosphingolipid and its production | |
JPH0730001B2 (en) | Novel cinnamic acid amide derivative and pharmaceuticals containing the same | |
DK170399B1 (en) | Naphthalene derivatives of the benzonorborn, process for their preparation and pharmaceuticals and cosmetics containing such compounds | |
JP3043582B2 (en) | Flavanonol derivatives | |
WO2003082233A1 (en) | Allyl-phenol compounds in androgenic disorders | |
JPS597112A (en) | Hair cosmetic | |
JPS61194040A (en) | Unsaturated alicyclic derivative and therapeutical and cosmetic use | |
KR20190022154A (en) | Composition containing trimethyl cyclohexen compound for promoting hair sprouting or hair growth | |
JP2000072650A (en) | Agent for external use for skin |